125 related articles for article (PubMed ID: 5311030)
1. Long-acting thyroid stimulator in thyrotoxic monozygous twins.
Priest WM
Br Med J; 1970 Jul; 3(5716):205. PubMed ID: 5311030
[No Abstract] [Full Text] [Related]
2. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
Bonnyns M; Vanhaelst L
J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
[No Abstract] [Full Text] [Related]
3. LATS protector, the human thyroid stimulator.
Adams DD
N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
[No Abstract] [Full Text] [Related]
4. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
[No Abstract] [Full Text] [Related]
5. The role of long acting thyroid stimulator in neonatal thyrotoxicosis.
Maisey MN; Stimmler L
Clin Endocrinol (Oxf); 1972 Jan; 1(1):81-90. PubMed ID: 4677121
[No Abstract] [Full Text] [Related]
6. Thyrotoxicosis and Hashimoto goitre in a pair of monozygotic twins with serum long-acting thyroid stimulator.
Jayson MI; Doniach D; Benhamou-Glynn N; Roitt IM; el Kabir DJ
Lancet; 1967 Jul; 2(7505):15-8. PubMed ID: 4165437
[No Abstract] [Full Text] [Related]
7. Pathogenesis of iodine-induced thyrotoxicosis: studies in northern Tasmania.
Vidor GI; Stewart JC; Wall JR; Wangel A; Hetzel BS
J Clin Endocrinol Metab; 1973 Dec; 37(6):901-9. PubMed ID: 4753432
[No Abstract] [Full Text] [Related]
8. Long-acting thyroid stimulator in euthyroid relatives of thyrotoxic patients.
Wall JR; Good BF; Hetzel BS
Lancet; 1969 Nov; 2(7629):1024-6. PubMed ID: 4187540
[No Abstract] [Full Text] [Related]
9. Changes in LATS and other thyoid autoantibody levels with therapy.
Kilpatrick JA
N Z Med J; 1974 Dec; 80(529):495-6. PubMed ID: 4532201
[No Abstract] [Full Text] [Related]
10. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
[TBL] [Abstract][Full Text] [Related]
11. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
Mori T; Fisher J; Kriss JP
J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
[No Abstract] [Full Text] [Related]
12. The long-acting thyroid stimulator.
Munro DS
Curr Top Exp Endocrinol; 1971; 1():175-98. PubMed ID: 4350824
[No Abstract] [Full Text] [Related]
13. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
[No Abstract] [Full Text] [Related]
14. [LATS and thyroid antibody level in the blood in Basedow's disease].
Földes J; Takó J; Bános C; Gesztesi E; Varga I
Orv Hetil; 1968 Aug; 109(33):1799-804. PubMed ID: 5714825
[No Abstract] [Full Text] [Related]
15. Pituitary-thyroid function in thyrotoxic patients in relation to long-acting thyroid stimulator (LATS) levels.
Fukuchi M; Matsuoka T; Inoue T; Miyai K; Kumahara Y
Acta Endocrinol (Copenh); 1970 Dec; 65(4):577-82. PubMed ID: 5536685
[No Abstract] [Full Text] [Related]
16. Neonatal transient thyrotoxicosis resulting from maternal TSH-binding inhibitor immunoglobulins.
Yagi H; Takeuchi M; Nagashima K; Suzuki S; Kuroume T; Iida Y; Konishi J; Endo K
J Pediatr; 1983 Oct; 103(4):591-3. PubMed ID: 6137525
[No Abstract] [Full Text] [Related]
17. [Cytogenetic studies in patients with thyroiditis and LATS and antibody-positive hyperthyroidism].
Tolksdorf M; Schemmel K; Mühlenstedt D; Uthgenannt H; Müller W
Schweiz Med Wochenschr; 1969 Jul; 99(30):1082-5. PubMed ID: 5351142
[No Abstract] [Full Text] [Related]
18. [The long-acting thyroid stimulator (LATS) in untreated and I-131 treated hyperthyreoses, following total thyroidectomy, as well as its relation to thyroid antibodies].
Ziemke A; Weisbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W
Klin Wochenschr; 1968 Oct; 46(19):1025-7. PubMed ID: 5727481
[No Abstract] [Full Text] [Related]
19. Relation between thyroid function and serum levels of long-acting thyroid stimulator.
Davis JC; Hipkin LJ; Summers VK; Gimlette TM
Acta Endocrinol (Copenh); 1975 Jul; 79(3):451-8. PubMed ID: 1173501
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
[No Abstract] [Full Text] [Related]
[Next] [New Search]
